Teva Women's Health clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Dec 23, 2008 · source ↗
The registry lists 2 studies whose lead sponsor is Teva Women's Health. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 13, 2015.
- 2studies on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Teva Women's Health became part of Teva Pharmaceutical Industries, Ltd.
- 0
- First submitted after Teva Women's Health became part of Teva Pharmaceutical Industries, Ltd.
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Teva Women's Health’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Ethinyl Estradiol1 in phase 30 open · 1
- Levonorgestrel1 in phase 30 open · 1
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed2100%
Over the years
- 109
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Teva Women's Health2 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Teva Pharmaceutical Industries, Ltd. studies →
- A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy WomenCompletedNCT01252186Phase 2
Sponsor listed in the registry: Teva Women's Health · First submitted after Teva Women's Health became part of Teva Pharmaceutical Industries, Ltd.
- A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of PregnancyCompletedNCT00996580Phase 3
Sponsor listed in the registry: Teva Women's Health · First submitted after Teva Women's Health became part of Teva Pharmaceutical Industries, Ltd.